Your browser doesn't support javascript.
loading
MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma.
Kinget, Lisa; Roussel, Eduard; Verbiest, Annelies; Albersen, Maarten; Rodríguez-Antona, Cristina; Graña-Castro, Osvaldo; Inglada-Pérez, Lucía; Zucman-Rossi, Jessica; Couchy, Gabrielle; Job, Sylvie; de Reyniès, Aurélien; Laenen, Annouschka; Baldewijns, Marcella; Beuselinck, Benoit.
Afiliação
  • Kinget L; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Roussel E; Department of Urology, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Verbiest A; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Albersen M; Department of Urology, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Rodríguez-Antona C; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.
  • Graña-Castro O; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.
  • Inglada-Pérez L; Department of Statistics and Operational Research, Faculty of Medicine, Complutense University, 28040 Madrid, Spain.
  • Zucman-Rossi J; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, INSERM, Functional Genomics of Solid Tumors Laboratory, équipe Labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology, F-75006 Paris, France.
  • Couchy G; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, INSERM, Functional Genomics of Solid Tumors Laboratory, équipe Labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology, F-75006 Paris, France.
  • Job S; Programme Cartes d'Identité des Tumeurs, Ligue Nationale Contre le Cancer, F-75006 Paris, France.
  • de Reyniès A; Programme Cartes d'Identité des Tumeurs, Ligue Nationale Contre le Cancer, F-75006 Paris, France.
  • Laenen A; Department of Biostatistics, KU Leuven, 3000 Leuven, Belgium.
  • Baldewijns M; Department of Pathology, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Beuselinck B; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, 3000 Leuven, Belgium.
Cancers (Basel) ; 13(12)2021 Jun 21.
Article em En | MEDLINE | ID: mdl-34205829
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Suíça